Literature DB >> 29095968

Characterization of the Glucagonlike Peptide-1 Receptor in Male Mouse Brain Using a Novel Antibody and In Situ Hybridization.

Casper Bo Jensen1,2, Charles Pyke1, Morten Grønbech Rasch1, Anders Bjorholm Dahl2, Lotte Bjerre Knudsen1, Anna Secher1.   

Abstract

Glucagonlike peptide 1 (GLP-1) is a physiological regulator of appetite, and long-acting GLP-1 receptor (GLP-1R) agonists lower food intake and body weight in both human and animal studies. The effects are mediated through brain GLP-1Rs, and several brain nuclei expressing the GLP-1R may be involved. To date, the mapping of the complete location of GLP-1R protein in the brain has been challenged by lack of good antibodies and the discrepancy between mRNA and protein, especially relevant in neuronal axonal processes. Here, we present a specific monoclonal GLP-1R antibody for immunohistochemistry with murine tissue and show detailed distribution of GLP-1R expression, as well as mapping of GLP-1R mRNA by nonradioactive in situ hybridization. Semiautomated image analysis was performed to map the GLP-1R distribution to atlas plates from the Allen Institute for Brain Science. The GLP-1R was abundantly expressed in numerous regions, including the septal nucleus, hypothalamus, and brain stem. GLP-1R protein expression was also observed on neuronal projections in brain regions devoid of any mRNA that has not been observed in earlier reports. Taken together, these findings provide knowledge on GLP-1R expression in neuronal cell bodies and neuronal projections.
Copyright © 2018 Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29095968     DOI: 10.1210/en.2017-00812

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  29 in total

Review 1.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

2.  Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves.

Authors:  Fahima Mayer; Amanda L Gunawan; Patrick Tso; Gregory W Aponte
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-05-18       Impact factor: 4.052

3.  A genetic map of the mouse dorsal vagal complex and its role in obesity.

Authors:  Mette Q Ludwig; Wenwen Cheng; Desiree Gordian; Julie Lee; Sarah J Paulsen; Stine N Hansen; Kristoffer L Egerod; Pernille Barkholt; Christopher J Rhodes; Anna Secher; Lotte Bjerre Knudsen; Charles Pyke; Martin G Myers; Tune H Pers
Journal:  Nat Metab       Date:  2021-03-25

4.  Expression of glucagon-like peptide 1 receptor in neuropeptide Y neurons of the arcuate nucleus in mice.

Authors:  Yvette Ruska; Anett Szilvásy-Szabó; Dóra Kővári; Andrea Kádár; Lilla Mácsai; Richárd Sinkó; Erik Hrabovszky; Balázs Gereben; Csaba Fekete
Journal:  Brain Struct Funct       Date:  2021-10-01       Impact factor: 3.270

Review 5.  The role of glucagon-like peptide 1 (GLP-1) in addictive disorders.

Authors:  Mette Kruse Klausen; Morgane Thomsen; Gitta Wortwein; Anders Fink-Jensen
Journal:  Br J Pharmacol       Date:  2022-02       Impact factor: 9.473

6.  Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor.

Authors:  Ila Mishra; Wei Rose Xie; Juan C Bournat; Yang He; Chunmei Wang; Elizabeth Sabath Silva; Hailan Liu; Zhiqiang Ku; Yinghua Chen; Bernadette O Erokwu; Peilin Jia; Zhongming Zhao; Zhiqiang An; Chris A Flask; Yanlin He; Yong Xu; Atul R Chopra
Journal:  Cell Metab       Date:  2022-03-16       Impact factor: 31.373

7.  Brain uptake pharmacokinetics of incretin receptor agonists showing promise as Alzheimer's and Parkinson's disease therapeutics.

Authors:  Therese S Salameh; Elizabeth M Rhea; Konrad Talbot; William A Banks
Journal:  Biochem Pharmacol       Date:  2020-08-02       Impact factor: 5.858

8.  Semaglutide lowers body weight in rodents via distributed neural pathways.

Authors:  Sanaz Gabery; Casper G Salinas; Sarah J Paulsen; Jonas Ahnfelt-Rønne; Tomas Alanentalo; Arian F Baquero; Stephen T Buckley; Erzsébet Farkas; Csaba Fekete; Klaus S Frederiksen; Hans Christian C Helms; Jacob F Jeppesen; Linu M John; Charles Pyke; Jane Nøhr; Tess T Lu; Joseph Polex-Wolf; Vincent Prevot; Kirsten Raun; Lotte Simonsen; Gao Sun; Anett Szilvásy-Szabó; Hanni Willenbrock; Anna Secher; Lotte Bjerre Knudsen; Wouter Frederik Johan Hogendorf
Journal:  JCI Insight       Date:  2020-03-26

Review 9.  Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation.

Authors:  Brent A McLean; Chi Kin Wong; Jonathan E Campbell; David J Hodson; Stefan Trapp; Daniel J Drucker
Journal:  Endocr Rev       Date:  2021-03-15       Impact factor: 19.871

Review 10.  Actions of glucagon-like peptide-1 receptor ligands in the gut.

Authors:  Jens Juul Holst; Daniel Bjørklund Andersen; Kaare Villum Grunddal
Journal:  Br J Pharmacol       Date:  2021-08-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.